Gregory Simon is a Psychiatry physician. ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
310 15th Ave E
Seattle, WA 981125103
Telephone
206-326-2200Provider last certified this registry record 6 May 2021.
Clinical trials
- Pilot Trial of Peer Support for Bipolar Disorder
Sponsor: Kaiser Permanente
- The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort
Sponsor: Duke University
- Feasibility of Depression Care Management by E-mail
Sponsor: Kaiser Permanente
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
97.4%Atypical Antipsychotic18.4%Risperidone17%Clozapine17%Aripiprazole15%Quetiapine Fumarate14%Vraylar14%Olanzapine10%Lurasidone Hcl8%Ziprasidone Hcl5%Part D<11 patientsBenzodiazepine14%Clonazepam64%Lorazepam14%Temazepam12%Alprazolam10%Part D<11 patients+ 11 more classes in this area
Cardiovascular
2.6%Central alpha-2 Adrenergic Agonist2.6%Clonidine Hcl69%Guanfacine Hcl31%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
15 NIH research awards on record, funded 1991–2018 per NIH RePORTER. The latest:
- Pragmatic Trial of Population-based Programs to Prevent Suicide Attempt
Kaiser Foundation Health Plan of Washington
FY2018$1,296,600UH3MH007755 - Mental Health Research Network II
Kaiser Foundation Health Plan of Washington
FY2017$1,912,330U19MH092201 - Pragmatic Trial of Population-based Programs to Prevent Suicide Attempt
Kaiser Foundation Health Plan of Washington
FY2017$1,587,679UH3MH007755
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Philip Scheltens
Inserm
Rafael Tabarés‐Seisdedos
Universitat de València
Nick C. Fox
UK Dementia Research Institute
Perminder S. Sachdev
Department of Health and Aged Care
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”